Abstract

Subject: Cardiovascular disease, as a very common and serious coexisting disease in diabetic patients, and is one of the risk factors that seriously affect the prognosis and complications of surgical patients. Previous studies have shown that sevoflurane post-conditioning (SPostC) exerts a protective effect against myocardial ischemia/reperfusion injury by HIF-1α, but the protective effect is weakened or even disappeared under hyperglycemia. This study aims to explore whether regulating the HIF-1α/MIF/AMPK signaling pathway can restore the protective effect and reveal the mechanism of SPostC on cardiomyocyte hypoxia/reoxygenation injury under high glucose conditions. Methods: H9c2 cardiomyocytes were cultured in normal and high-concentration glucose medium to establish a hypoxia/reoxygenation (H/R) injury model of cardiomyocytes. SPostC was performed with 2.4% sevoflurane for 15 min before reoxygenation. Cell damage was determined by measuring cell viability, lactate dehydrogenase activity, and apoptosis; Testing cell energy metabolism by detecting reactive oxygen species (ROS) generation, ATP content and mitochondrial membrane potential; Analysis of the change of HIF-1α, MIF and AMPKα mRNA expression by RT-PCR. Western blotting was used to examine the expression of HIF-1α, MIF, AMPKα and p-AMPKα proteins. HIF-1α and MIF inhibitors and agonists were administered 40 min before hypoxia. Results: 1) SPostC exerts a protective effect by increasing cell viability, reducing LDH levels and cell apoptosis under low glucose (5 μM) after undergoing H/R injury; 2) High glucose concentration (35 μM) eliminated the cardioprotective effect of SPostC, which is manifested by a significantly decrease in the protein and mRNA expression level of the HIF-1α/MIF/AMPK signaling pathway, accompanied by decreased cell viability, increased LDH levels and apoptosis, increased ROS production, decreased ATP synthesis, and decreased mitochondrial membrane potential; 3. Under high glucose (35 μM), the expression levels of HIF-1α and MIF were up-regulated by using agonists, which can significantly increase the level of p-AMPKα protein, and the cardioprotective effect of SPostC was restored. Conclusion: The signal pathway of HIF-1α/MIF/AMPK of H9c2 cardiomyocytes may be the key point of SPostC against H/R injure. The cardioprotective of SPostC could be restored by upregulating the protein expression of HIF-1α and MIF under hyperglycemia.

Highlights

  • The incidence of diabetes is increasing year by year, and it is showing a trend of getting younger

  • Cardiomyocytes are Damaged Under High Glucose Condition and the Cardioprotective Effect Mediated by SpostC is Weakened

  • In this study, compared with N + H/R group, N + H/R + SPostC group significantly reduces cell damage, which is shown as increased cell viability (Figure 2A), and decreased LDH content (Figure 2B); Simultaneously accompanied by reduced the rate of cell apoptosis, which is detected by flow cytometry (Figures 2C,D); the damage of myocardial cells was increased again when the Hypoxia-inducible factor-1α (HIF-1α) inhibitor (YC-1) and migration inhibitory factor (MIF) inhibitor (ISO-1)were used respectively (Figures 2A–C)

Read more

Summary

Introduction

The incidence of diabetes is increasing year by year, and it is showing a trend of getting younger. It has become a global public health problem that seriously threatens human health. Studies have confirmed that long-term diabetes will produce many complications, including vascular endothelial dysfunction (Xu et al, 2019), exacerbating myocardial injure caused by ischemia/reperfusion (Ruan et al, 2019). Studies have found that the incidence of myocardial ischemia in diabetic patients is 1.45–2.99 times higher than that of non-diabetic patients (Aniskevich et al, 2017), and the incidence of perioperative heart-related complications is about 5 times higher than that of non-diabetic patients (Liu et al, 2016), which is a serious safety threat for surgical patients. Seeking effective myocardial protection strategies for diabetic patients during the perioperative period is an very important scientific issue

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.